Dr. Stuart Sievers, PhD

Senior Director, Discovery Research at Capstan Therapeutics

Speaker

Dr. Stuart Sievers is the Senior Director of Discovery Research at Capstan Therapeutics. His team focuses on antibody and chimeric antigen receptor (CAR) discovery and engineering, supporting the development of targeted lipid nanoparticles to engineer cells in vivo. Previously, Stuart worked at Kite Pharma, directing antibody discovery and CAR screening efforts to support the development of clinical- and commercial-stage cell therapies. Stuart earned his undergraduate degree in Biochemistry from UC Berkeley, his PhD in Biochemistry from UCLA under David Eisenberg, and completed postdoctoral research at Caltech with Pamela Bjorkman. His research has led to publications and patents on a variety of topics, including amyloid fibril formation and inhibition, antibody and CAR design, and novel reagents for CAR detection.